QLUPOD AG: QluPod AG prepares first delivery for the European market

Herisau (pta030/30.08.2023/13:03) - Press Release QluPod AG

Herisau, Switzerland QluPod AG, 30 August 2023 (www.qlupod.com)

QluPod AG is pleased to announce that the company has initiated the first shipment of the innovative QluPod health monitor in the European market. The upcoming launch underlines the company's commitment to provide a high quality health solution for mobile use at home and in telemedicine.

Production of the first 1,000 units of the QluPod health monitor has been agreed and delivery to end customers is planned for October 2023. "The delivery of the first 1,000 units was successfully launched as planned before the end of Q3 2023," says Aidan Burley, Head of Sales & Marketing at QluPod AG. "We are thrilled by the positive response and the interest of customers in our Health Monitor for preventive health care and to support telemedicine."

Exclusive savings with preorder

The company invites all health-conscious consumers to take advantage of the Health Monitor launch to measure, monitor and report six important vital signs to their doctor or other authorised persons with just one device. For a short time only, customers have the opportunity to benefit from a special 40% discount on the retail price if they decide to pre-order.

In order to provide access to as many users as possible, the company has set up official sales pages on its homepage ( https://qlupod.eu/ ) for both the British market and the entire DACH region. This ensures that interested parties from these regions can easily access all information and order the innovative Health Monitor at a preferential price even before its market launch.

Strategic partnership for sales promotion

To further increase the market presence and brand awareness of the Health Monitor, the company has appointed two marketing agencies specialised in telemedicine and B2C. This strategic partnership helps to raise awareness of the Health Monitor's innovative capabilities in health monitoring of blood pressure, heart rate, blood glucose, ECG, blood oxygen and body temperature.

QluPod Free App for seamless integration

To ensure the seamless integration of the Health Monitor into the users' everyday life, the QluPod Free App is available. The app enables the transmission and display of the measured vital signs on smartphones and tablets. The Android version is already available in the Google Play Store, while the iOS version for iPhones will be available in the Apple Store in the next few days.

For more information and to order the QluPod Health Monitor, please visit the company's official website ( https://qlupod.eu/ ) or contact the QluPod team by phone or email.

About QluPod:

QluPod AG is a start-up company in the field of telemedicine and develops innovative solutions to make patient care efficient and cost-effective. With the QluPod device and associated software, the company aims to shape the future of healthcare. The offer is aimed at hospitals, care facilities, medical professionals as well as private individuals who want to monitor their health on their own responsibility.

For more information about QluPod AG and our products, please visit our website at www.qlupod.com.

Disclaimer:
This publication constitutes neither an offer to sell nor a solicitation to buy any securities. To the extent that forward-looking statements are contained in this document, they are not statements of fact and are identified by the words "expect", "believe", "estimate", "intend", "seek", "assume" and similar expressions. These statements express the intentions, beliefs or current expectations and assumptions of QluPod AG and are based on current plans, estimates and projections made by QluPod AG to the best of its knowledge, but are not guarantees of future performance. Forward-looking statements are subject to risks and uncertainties, most of which are difficult to predict and are usually beyond the control of QluPod AG. It should be taken into account that actual events or developments may differ materially from those indicated or contained in the forward-looking statements.

(Ende)